TY - JOUR
T1 - Optimal margin width in breast conservation therapy
T2 - A review of the current guidelines and literature
AU - Hosseini, Ava
AU - Chandrasekaran, Bindupriya
AU - Aft, Rebecca
AU - Blair, Sarah
N1 - Publisher Copyright:
© Springer Science+Business Media New York 2014.
PY - 2015/3/28
Y1 - 2015/3/28
N2 - Randomized trials have clearly established breast conservation therapy (BCT) as appropriate treatment for early-stage invasive breast cancer. Current evidence shows that positive margins confer a greater than twofold risk of ipsilateral breast tumor recurrence. Thus, patients who have positive margins after BCT warrant re-excision. With regard to negative margins, however, the optimal negative margin width remains unclear. This article reviews the recent guidelines set forth by the Society of Surgical Oncology and the American Society of Radiation Oncology regarding the margin width in stage I and II invasive breast cancer. We also discuss the controversies related to implementation of these guidelines.
AB - Randomized trials have clearly established breast conservation therapy (BCT) as appropriate treatment for early-stage invasive breast cancer. Current evidence shows that positive margins confer a greater than twofold risk of ipsilateral breast tumor recurrence. Thus, patients who have positive margins after BCT warrant re-excision. With regard to negative margins, however, the optimal negative margin width remains unclear. This article reviews the recent guidelines set forth by the Society of Surgical Oncology and the American Society of Radiation Oncology regarding the margin width in stage I and II invasive breast cancer. We also discuss the controversies related to implementation of these guidelines.
KW - Breast conservation therapy
KW - Ipsilateral breast tumor recurrence
KW - Margin re-excision
KW - Margin width
UR - http://www.scopus.com/inward/record.url?scp=84938423799&partnerID=8YFLogxK
U2 - 10.1007/s12609-014-0170-z
DO - 10.1007/s12609-014-0170-z
M3 - Article
AN - SCOPUS:84938423799
SN - 1943-4588
VL - 7
SP - 48
EP - 52
JO - Current Breast Cancer Reports
JF - Current Breast Cancer Reports
IS - 1
ER -